Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab

Purpose. To assess visual function and its response to serial intravitreal ranibizumab (Lucentis, Genentech) in patients with neovascular age-related macular degeneration (nv-AMD). Methods. Forty-seven eyes of 47 patients with nv-AMD, and corrected distance visual acuity (CDVA) logMAR 0.7 or better,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabour-Pickett, Sarah, Loughman, James, Nolan, John M., Stack, Jim, Pesudovs, Konrad, Meagher, Katherine A., Beatty, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595676/
https://www.ncbi.nlm.nih.gov/pubmed/23533703
http://dx.doi.org/10.1155/2013/268438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595676/
https://www.ncbi.nlm.nih.gov/pubmed/23533703
http://dx.doi.org/10.1155/2013/268438

Ejemplares similares